Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1600 per EA under NDC 68462020090. Its NADAC has been published 116 times since Apr 10, 2024.
Strength
40 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462020090
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090032On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 116 times since Apr 10, 2024, and over the history we have for it it has declined 38.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1600 per EA |
|---|---|
| All-time high | $0.2582 (Apr 10, 2024) |
| All-time low | $0.1274 (Nov 20, 2024) |
| 52-week high | $0.1881 |
| 52-week low | $0.1600 |
| Median price | $0.1786 |
| Average price | $0.1813 |
| Largest weekly change | -33.0% (Nov 20, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1600 per EA (NDC 68462020090), effective Jun 24, 2026.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 38.1%. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Apr 10, 2024, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1274 (Nov 20, 2024) to a high of $0.2582 (Apr 10, 2024), with a median of $0.1786 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN 40 MG TABLET, but none are currently priced below it.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 68462020090) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification